California State Teachers Retirement System Has $9.14 Million Holdings in DaVita Inc. (NYSE:DVA) (2024)

Posted by Defense World Staff on Jun 9th, 2024

California State Teachers Retirement System raised its position in DaVita Inc. (NYSE:DVA – Free Report) by 4.2% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 87,217 shares of the company’s stock after purchasing an additional 3,543 shares during the period. California State Teachers Retirement System owned 0.10% of DaVita worth $9,137,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. Hanseatic Management Services Inc. acquired a new position in DaVita in the third quarter valued at $36,000. Principal Securities Inc. bought a new stake in shares of DaVita during the 4th quarter valued at about $37,000. GAMMA Investing LLC acquired a new stake in DaVita during the fourth quarter worth approximately $60,000. Quest Partners LLC bought a new stake in DaVita in the fourth quarter worth approximately $74,000. Finally, Tacita Capital Inc acquired a new position in DaVita in the third quarter valued at approximately $118,000. 90.12% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Barbara J. Desoer sold 5,030 shares of the stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $138.81, for a total transaction of $698,214.30. Following the completion of the transaction, the director now directly owns 10,954 shares of the company’s stock, valued at approximately $1,520,524.74. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.00% of the company’s stock.

DaVita Stock Performance

DVA opened at $143.18 on Friday. DaVita Inc. has a 1-year low of $71.51 and a 1-year high of $147.93. The company has a market cap of $12.56 billion, a price-to-earnings ratio of 16.27, a PEG ratio of 1.10 and a beta of 0.96. The company’s fifty day moving average price is $136.79 and its two-hundred day moving average price is $122.54. The company has a current ratio of 1.43, a quick ratio of 1.37 and a debt-to-equity ratio of 7.95.

DaVita (NYSE:DVA – Get Free Report) last posted its earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.43. The company had revenue of $3.07 billion for the quarter, compared to analyst estimates of $3.03 billion. DaVita had a net margin of 6.61% and a return on equity of 68.52%. The firm’s revenue was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.58 EPS. On average, analysts expect that DaVita Inc. will post 9.62 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently weighed in on DVA. UBS Group lifted their price objective on shares of DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, February 14th. Barclays lifted their price target on shares of DaVita from $133.00 to $150.00 and gave the company an “equal weight” rating in a research note on Monday, May 6th. StockNews.com downgraded DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Finally, Truist Financial upped their price target on DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a research note on Wednesday, May 15th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, DaVita has an average rating of “Moderate Buy” and a consensus target price of $144.67.

Get Our Latest Stock Report on DaVita

About DaVita

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.